Australian SOciety of Molecular Imaging

HOME
News
Symposiums
Board Members
Contact ASMI

The blog.

Get inspired, Read our posts

New nuclear medicine hand book

A place for your subtitle 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed malesuada faucibus ex nec ultricies. Donec mattis egestas nisi non pretium.

A place for your subtitle 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed malesuada faucibus ex nec ultricies. Donec mattis egestas nisi non pretium.

A place for your subtitle 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed malesuada faucibus ex nec ultricies. Donec mattis egestas nisi non pretium.

A place for your subtitle 4

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed malesuada faucibus ex nec ultricies. Donec mattis egestas nisi non pretium.

Fibroblast activation protein, the new FDG of oncology imaging?

4/12/2020

17/11/2020

5/11/2020

21/7/2020

15/5/2020

7/5/2020

22/3/2020

20/12/2019

Check out our Twitter feed

Tweets by Au_Soc_Mol_Imag

ASMI IS AFFILIATED WITH THE FEDERATION OF ASIAN SOCIETIES FOR MOLECULAR IMAGING (FASMI) AND THE WORLD MOLECULAR IMAGING SOCIETY (WMIS)

australia.molecular.imaging@gmail.com

Website maintained by Xiaowei Wang/Nicole Dmochowska

Australian SOciety of Molecular Imaging

The blog.

Get inspired, Read our posts

New nuclear medicine hand book

A place for your subtitle 1

Your post title 2

A place for your subtitle 2

Your post title 3

A place for your subtitle 3

Your post title 1 4

A place for your subtitle 4

MOLECULAR IMAGING, DOWN UNDER

Featured news and publications

Fibroblast activation protein, the new FDG of oncology imaging?

4/12/2020

Visualizing chemotherapy-induced cell death using Zirconium-89-labeled APOMAB®

17/11/2020

Congratulations to Dr Xiaowei Wang for her promotion to Adjunct Associate Professor at Monash University

5/11/2020

Alterations in GABA-a receptor density revealed in a model of prenatal ethanol exposure using 18-F-AH114726

21/7/2020

67-Cu-CuSarTATE shows potent antitumour activity in a model of somatostatin positive neuroendocrine tumours

15/5/2020

Targeted beta therapy of prostate cancer with 177-Lu-labelled antibody against glypican-1

7/5/2020

PSMA PET-CT could transform the management of high-risk localised prostate cancer

22/3/2020

Synthesis and evaluation of an 18-F PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)

20/12/2019

Check out our Twitter feed

ASMI IS AFFILIATED WITH THE FEDERATION OF ASIAN SOCIETIES FOR MOLECULAR IMAGING (FASMI) AND THE WORLD MOLECULAR IMAGING SOCIETY (WMIS)